Industry Research Reports

Home > Reports > Service & Software > Global Tissue-Based Diagnostics Market Insights, Forecast to 2030

Global Tissue-Based Diagnostics Market Insights, Forecast to 2030

Industry: Service & Software

Published Date: 2024-04-08

Pages: 110 Pages

Report ld: 2769485

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Tissue-Based Diagnostics Market Size(US$)

CAGR 2024-2030

6.7%

Market Size,2030

USD 8,054.2

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 5,458 million

Market Forecast in 2030(Value)

US$ 8,054.2 million

CAGR

6.7%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Market Analysis and Insights: Global Tissue-Based Diagnostics Market

The global Tissue-Based Diagnostics market is projected to grow from US$ 5458 million in 2024 to US$ 8054.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Tissue-Based Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Tissue-Based Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Tissue-Based Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tissue-Based Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Tissue-Based Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Tissue-Based Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

Roche
Danaher
Thermo Fisher Scientific
Abbott
Agilent Technologies
ABCAM
Merck
BD
Hologic
Bio Rad

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Digital Pathology and Workflow Management
Special Staining

Segment by Application

Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Other

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tissue-Based Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Immunohistochemistry (IHC)

1.2.3 In Situ Hybridization (ISH)

1.2.4 Digital Pathology and Workflow Management

1.2.5 Special Staining

1.3 Market by Application

1.3.1 Global Tissue-Based Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Research Laboratories

1.3.4 Pharmaceutical Companies

1.3.5 Contract Research Organizations

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tissue-Based Diagnostics Market Perspective (2019-2030)

2.2 Global Tissue-Based Diagnostics Growth Trends by Region

2.2.1 Tissue-Based Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Tissue-Based Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Tissue-Based Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Tissue-Based Diagnostics Market Dynamics

2.3.1 Tissue-Based Diagnostics Industry Trends

2.3.2 Tissue-Based Diagnostics Market Drivers

2.3.3 Tissue-Based Diagnostics Market Challenges

2.3.4 Tissue-Based Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Tissue-Based Diagnostics by Players

3.1.1 Global Tissue-Based Diagnostics Revenue by Players (2019-2024)

3.1.2 Global Tissue-Based Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Tissue-Based Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Tissue-Based Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Tissue-Based Diagnostics Market Concentration Ratio

3.4.1 Global Tissue-Based Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tissue-Based Diagnostics Revenue in 2023

3.5 Global Key Players of Tissue-Based Diagnostics Head office and Area Served

3.6 Global Key Players of Tissue-Based Diagnostics, Product and Application

3.7 Global Key Players of Tissue-Based Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tissue-Based Diagnostics Breakdown Data by Type

4.1 Global Tissue-Based Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Tissue-Based Diagnostics Forecasted Market Size by Type (2025-2030)

5 Tissue-Based Diagnostics Breakdown Data by Application

5.1 Global Tissue-Based Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Tissue-Based Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Tissue-Based Diagnostics Market Size (2019-2030)

6.2 North America Tissue-Based Diagnostics Market Size by Type

6.2.1 North America Tissue-Based Diagnostics Market Size by Type (2019-2024)

6.2.2 North America Tissue-Based Diagnostics Market Size by Type (2025-2030)

6.2.3 North America Tissue-Based Diagnostics Market Share by Type (2019-2030)

6.3 North America Tissue-Based Diagnostics Market Size by Application

6.3.1 North America Tissue-Based Diagnostics Market Size by Application (2019-2024)

6.3.2 North America Tissue-Based Diagnostics Market Size by Application (2025-2030)

6.3.3 North America Tissue-Based Diagnostics Market Share by Application (2019-2030)

6.4 North America Tissue-Based Diagnostics Market Size by Country

6.4.1 North America Tissue-Based Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Tissue-Based Diagnostics Market Size by Country (2019-2024)

6.4.3 North America Tissue-Based Diagnostics Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Tissue-Based Diagnostics Market Size (2019-2030)

7.2 Europe Tissue-Based Diagnostics Market Size by Type

7.2.1 Europe Tissue-Based Diagnostics Market Size by Type (2019-2024)

7.2.2 Europe Tissue-Based Diagnostics Market Size by Type (2025-2030)

7.2.3 Europe Tissue-Based Diagnostics Market Share by Type (2019-2030)

7.3 Europe Tissue-Based Diagnostics Market Size by Application

7.3.1 Europe Tissue-Based Diagnostics Market Size by Application (2019-2024)

7.3.2 Europe Tissue-Based Diagnostics Market Size by Application (2025-2030)

7.3.3 Europe Tissue-Based Diagnostics Market Share by Application (2019-2030)

7.4 Europe Tissue-Based Diagnostics Market Size by Country

7.4.1 Europe Tissue-Based Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Tissue-Based Diagnostics Market Size by Country (2019-2024)

7.4.3 Europe Tissue-Based Diagnostics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Tissue-Based Diagnostics Market Size (2019-2030)

8.2 China Tissue-Based Diagnostics Market Size by Type

8.2.1 China Tissue-Based Diagnostics Market Size by Type (2019-2024)

8.2.2 China Tissue-Based Diagnostics Market Size by Type (2025-2030)

8.2.3 China Tissue-Based Diagnostics Market Share by Type (2019-2030)

8.3 China Tissue-Based Diagnostics Market Size by Application

8.3.1 China Tissue-Based Diagnostics Market Size by Application (2019-2024)

8.3.2 China Tissue-Based Diagnostics Market Size by Application (2025-2030)

8.3.3 China Tissue-Based Diagnostics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Tissue-Based Diagnostics Market Size (2019-2030)

9.2 Asia Tissue-Based Diagnostics Market Size by Type

9.2.1 Asia Tissue-Based Diagnostics Market Size by Type (2019-2024)

9.2.2 Asia Tissue-Based Diagnostics Market Size by Type (2025-2030)

9.2.3 Asia Tissue-Based Diagnostics Market Share by Type (2019-2030)

9.3 Asia Tissue-Based Diagnostics Market Size by Application

9.3.1 Asia Tissue-Based Diagnostics Market Size by Application (2019-2024)

9.3.2 Asia Tissue-Based Diagnostics Market Size by Application (2025-2030)

9.3.3 Asia Tissue-Based Diagnostics Market Share by Application (2019-2030)

9.4 Asia Tissue-Based Diagnostics Market Size by Region

9.4.1 Asia Tissue-Based Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Tissue-Based Diagnostics Market Size by Region (2019-2024)

9.4.3 Asia Tissue-Based Diagnostics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Tissue-Based Diagnostics Introduction

11.1.4 Roche Revenue in Tissue-Based Diagnostics Business (2019-2024)

11.1.5 Roche Recent Developments

11.2 Danaher

11.2.1 Danaher Company Details

11.2.2 Danaher Business Overview

11.2.3 Danaher Tissue-Based Diagnostics Introduction

11.2.4 Danaher Revenue in Tissue-Based Diagnostics Business (2019-2024)

11.2.5 Danaher Recent Developments

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Tissue-Based Diagnostics Introduction

11.3.4 Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (2019-2024)

11.3.5 Thermo Fisher Scientific Recent Developments

11.4 Abbott

11.4.1 Abbott Company Details

11.4.2 Abbott Business Overview

11.4.3 Abbott Tissue-Based Diagnostics Introduction

11.4.4 Abbott Revenue in Tissue-Based Diagnostics Business (2019-2024)

11.4.5 Abbott Recent Developments

11.5 Agilent Technologies

11.5.1 Agilent Technologies Company Details

11.5.2 Agilent Technologies Business Overview

11.5.3 Agilent Technologies Tissue-Based Diagnostics Introduction

11.5.4 Agilent Technologies Revenue in Tissue-Based Diagnostics Business (2019-2024)

11.5.5 Agilent Technologies Recent Developments

11.6 ABCAM

11.6.1 ABCAM Company Details

11.6.2 ABCAM Business Overview

11.6.3 ABCAM Tissue-Based Diagnostics Introduction

11.6.4 ABCAM Revenue in Tissue-Based Diagnostics Business (2019-2024)

11.6.5 ABCAM Recent Developments

11.7 Merck

11.7.1 Merck Company Details

11.7.2 Merck Business Overview

11.7.3 Merck Tissue-Based Diagnostics Introduction

11.7.4 Merck Revenue in Tissue-Based Diagnostics Business (2019-2024)

11.7.5 Merck Recent Developments

11.8 BD

11.8.1 BD Company Details

11.8.2 BD Business Overview

11.8.3 BD Tissue-Based Diagnostics Introduction

11.8.4 BD Revenue in Tissue-Based Diagnostics Business (2019-2024)

11.8.5 BD Recent Developments

11.9 Hologic

11.9.1 Hologic Company Details

11.9.2 Hologic Business Overview

11.9.3 Hologic Tissue-Based Diagnostics Introduction

11.9.4 Hologic Revenue in Tissue-Based Diagnostics Business (2019-2024)

11.9.5 Hologic Recent Developments

11.10 Bio Rad

11.10.1 Bio Rad Company Details

11.10.2 Bio Rad Business Overview

11.10.3 Bio Rad Tissue-Based Diagnostics Introduction

11.10.4 Bio Rad Revenue in Tissue-Based Diagnostics Business (2019-2024)

11.10.5 Bio Rad Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Tissue-Based Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Immunohistochemistry (IHC)

Table 3. Key Players of In Situ Hybridization (ISH)

Table 4. Key Players of Digital Pathology and Workflow Management

Table 5. Key Players of Special Staining

Table 6. Global Tissue-Based Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Tissue-Based Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Tissue-Based Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Tissue-Based Diagnostics Market Share by Region (2019-2024)

Table 10. Global Tissue-Based Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Tissue-Based Diagnostics Market Share by Region (2025-2030)

Table 12. Tissue-Based Diagnostics Market Trends

Table 13. Tissue-Based Diagnostics Market Drivers

Table 14. Tissue-Based Diagnostics Market Challenges

Table 15. Tissue-Based Diagnostics Market Restraints

Table 16. Global Tissue-Based Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Tissue-Based Diagnostics Revenue Share by Players (2019-2024)

Table 18. Global Top Tissue-Based Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue-Based Diagnostics as of 2023)

Table 19. Global Tissue-Based Diagnostics Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Tissue-Based Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Tissue-Based Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Tissue-Based Diagnostics, Product and Application

Table 23. Global Key Players of Tissue-Based Diagnostics, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Tissue-Based Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Tissue-Based Diagnostics Revenue Market Share by Type (2019-2024)

Table 27. Global Tissue-Based Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Tissue-Based Diagnostics Revenue Market Share by Type (2025-2030)

Table 29. Global Tissue-Based Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Tissue-Based Diagnostics Revenue Share by Application (2019-2024)

Table 31. Global Tissue-Based Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Tissue-Based Diagnostics Revenue Share by Application (2025-2030)

Table 33. North America Tissue-Based Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Tissue-Based Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Tissue-Based Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Tissue-Based Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Tissue-Based Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Tissue-Based Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Tissue-Based Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Tissue-Based Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Tissue-Based Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Tissue-Based Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Tissue-Based Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Tissue-Based Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Tissue-Based Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Tissue-Based Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Tissue-Based Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Tissue-Based Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Tissue-Based Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Tissue-Based Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Tissue-Based Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Tissue-Based Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Tissue-Based Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Tissue-Based Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Tissue-Based Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Tissue-Based Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Tissue-Based Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Tissue-Based Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 65. Roche Company Details

Table 66. Roche Business Overview

Table 67. Roche Tissue-Based Diagnostics Product

Table 68. Roche Revenue in Tissue-Based Diagnostics Business (2019-2024) & (US$ Million)

Table 69. Roche Recent Developments

Table 70. Danaher Company Details

Table 71. Danaher Business Overview

Table 72. Danaher Tissue-Based Diagnostics Product

Table 73. Danaher Revenue in Tissue-Based Diagnostics Business (2019-2024) & (US$ Million)

Table 74. Danaher Recent Developments

Table 75. Thermo Fisher Scientific Company Details

Table 76. Thermo Fisher Scientific Business Overview

Table 77. Thermo Fisher Scientific Tissue-Based Diagnostics Product

Table 78. Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (2019-2024) & (US$ Million)

Table 79. Thermo Fisher Scientific Recent Developments

Table 80. Abbott Company Details

Table 81. Abbott Business Overview

Table 82. Abbott Tissue-Based Diagnostics Product

Table 83. Abbott Revenue in Tissue-Based Diagnostics Business (2019-2024) & (US$ Million)

Table 84. Abbott Recent Developments

Table 85. Agilent Technologies Company Details

Table 86. Agilent Technologies Business Overview

Table 87. Agilent Technologies Tissue-Based Diagnostics Product

Table 88. Agilent Technologies Revenue in Tissue-Based Diagnostics Business (2019-2024) & (US$ Million)

Table 89. Agilent Technologies Recent Developments

Table 90. ABCAM Company Details

Table 91. ABCAM Business Overview

Table 92. ABCAM Tissue-Based Diagnostics Product

Table 93. ABCAM Revenue in Tissue-Based Diagnostics Business (2019-2024) & (US$ Million)

Table 94. ABCAM Recent Developments

Table 95. Merck Company Details

Table 96. Merck Business Overview

Table 97. Merck Tissue-Based Diagnostics Product

Table 98. Merck Revenue in Tissue-Based Diagnostics Business (2019-2024) & (US$ Million)

Table 99. Merck Recent Developments

Table 100. BD Company Details

Table 101. BD Business Overview

Table 102. BD Tissue-Based Diagnostics Product

Table 103. BD Revenue in Tissue-Based Diagnostics Business (2019-2024) & (US$ Million)

Table 104. BD Recent Developments

Table 105. Hologic Company Details

Table 106. Hologic Business Overview

Table 107. Hologic Tissue-Based Diagnostics Product

Table 108. Hologic Revenue in Tissue-Based Diagnostics Business (2019-2024) & (US$ Million)

Table 109. Hologic Recent Developments

Table 110. Bio Rad Company Details

Table 111. Bio Rad Business Overview

Table 112. Bio Rad Tissue-Based Diagnostics Product

Table 113. Bio Rad Revenue in Tissue-Based Diagnostics Business (2019-2024) & (US$ Million)

Table 114. Bio Rad Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tissue-Based Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Tissue-Based Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Immunohistochemistry (IHC) Features

Figure 4. In Situ Hybridization (ISH) Features

Figure 5. Digital Pathology and Workflow Management Features

Figure 6. Special Staining Features

Figure 7. Global Tissue-Based Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Tissue-Based Diagnostics Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Research Laboratories Case Studies

Figure 11. Pharmaceutical Companies Case Studies

Figure 12. Contract Research Organizations Case Studies

Figure 13. Other Case Studies

Figure 14. Tissue-Based Diagnostics Report Years Considered

Figure 15. Global Tissue-Based Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Tissue-Based Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Tissue-Based Diagnostics Market Share by Region: 2023 VS 2030

Figure 18. Global Tissue-Based Diagnostics Market Share by Players in 2023

Figure 19. Global Top Tissue-Based Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tissue-Based Diagnostics as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Tissue-Based Diagnostics Revenue in 2023

Figure 21. North America Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Tissue-Based Diagnostics Market Share by Type (2019-2030)

Figure 23. North America Tissue-Based Diagnostics Market Share by Application (2019-2030)

Figure 24. North America Tissue-Based Diagnostics Market Share by Country (2019-2030)

Figure 25. United States Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Tissue-Based Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 28. Europe Tissue-Based Diagnostics Market Share by Type (2019-2030)

Figure 29. Europe Tissue-Based Diagnostics Market Share by Application (2019-2030)

Figure 30. Europe Tissue-Based Diagnostics Market Share by Country (2019-2030)

Figure 31. Germany Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. France Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. U.K. Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Italy Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Russia Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Nordic Countries Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. China Tissue-Based Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 38. China Tissue-Based Diagnostics Market Share by Type (2019-2030)

Figure 39. China Tissue-Based Diagnostics Market Share by Application (2019-2030)

Figure 40. Asia Tissue-Based Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 41. Asia Tissue-Based Diagnostics Market Share by Type (2019-2030)

Figure 42. Asia Tissue-Based Diagnostics Market Share by Application (2019-2030)

Figure 43. Asia Tissue-Based Diagnostics Market Share by Region (2019-2030)

Figure 44. Japan Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. South Korea Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. China Taiwan Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. India Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Australia Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Size YoY (2019-2030) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Share by Type (2019-2030)

Figure 52. Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Share by Application (2019-2030)

Figure 53. Middle East, Africa, and Latin America Tissue-Based Diagnostics Market Share by Country (2019-2030)

Figure 54. Brazil Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Mexico Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Turkey Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Israel Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. GCC Countries Tissue-Based Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 60. Roche Revenue Growth Rate in Tissue-Based Diagnostics Business (2019-2024)

Figure 61. Danaher Revenue Growth Rate in Tissue-Based Diagnostics Business (2019-2024)

Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Tissue-Based Diagnostics Business (2019-2024)

Figure 63. Abbott Revenue Growth Rate in Tissue-Based Diagnostics Business (2019-2024)

Figure 64. Agilent Technologies Revenue Growth Rate in Tissue-Based Diagnostics Business (2019-2024)

Figure 65. ABCAM Revenue Growth Rate in Tissue-Based Diagnostics Business (2019-2024)

Figure 66. Merck Revenue Growth Rate in Tissue-Based Diagnostics Business (2019-2024)

Figure 67. BD Revenue Growth Rate in Tissue-Based Diagnostics Business (2019-2024)

Figure 68. Hologic Revenue Growth Rate in Tissue-Based Diagnostics Business (2019-2024)

Figure 69. Bio Rad Revenue Growth Rate in Tissue-Based Diagnostics Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 6.7% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

What was the global market size of Tissue-Based Diagnostics in 2024? shouQi

What is the annual compound growth rate of the global Tissue-Based Diagnostics market size from 2024 to 2030? shouQi

Which companies rank high in the global Tissue-Based Diagnostics market? shouQi

What was the global market size of Tissue-Based Diagnostics in 2030? shouQi

Related Reports

Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 6136 million in 2025 and is projected to reach US$ 9601 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 105
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2026
The global Tissue-Based Diagnostics market was valued at US$ 6136 million in 2025 and is anticipated to reach US$ 9601 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 110
USD 2900.00
(Single User License)
Global Tissue-Based Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tissue-Based Diagnostics market is projected to grow from US$ 5787 million in 2024 to US$ 9055 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 129
USD 4900.00
(Single User License)
Global Tissue-Based Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tissue-Based Diagnostics market size was US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 78
USD 4250.00
(Single User License)
Tissue-Based Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 99
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2025
The global market for Tissue-Based Diagnostics was valued at US$ 5787 million in the year 2024 and is projected to reach a revised size of US$ 9055 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published Date: 2025-02-21
Pages: 72
USD 2900.00
(Single User License)
Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5321 million in 2023 and is forecast to a readjusted size of US$ 8054.2 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030
Published Date: 2024-02-22
Pages: 110
USD 3950.00
(Single User License)
Global Tissue-Based Diagnostics Market Research Report 2024
The global Tissue-Based Diagnostics market was valued at US$ 5321 million in 2023 and is anticipated to reach US$ 8054.2 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Published Date: 2024-02-06
Pages: 81
USD 2900.00
(Single User License)

Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 6136 million in 2025 and is projected to reach US$ 9601 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-07-09
Pages: 105
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2026
The global Tissue-Based Diagnostics market was valued at US$ 6136 million in 2025 and is anticipated to reach US$ 9601 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-04-21
Pages: 110
USD 2900.00 (Single User License)
Global Tissue-Based Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tissue-Based Diagnostics market is projected to grow from US$ 5787 million in 2024 to US$ 9055 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 129
USD 4900.00 (Single User License)
Global Tissue-Based Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tissue-Based Diagnostics market size was US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 78
USD 4250.00 (Single User License)
Tissue-Based Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5787 million in 2024 and is forecast to a readjusted size of US$ 9055 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 99
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2025
The global market for Tissue-Based Diagnostics was valued at US$ 5787 million in the year 2024 and is projected to reach a revised size of US$ 9055 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Published: 2025-02-21
Pages: 72
USD 2900.00 (Single User License)
Tissue-Based Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Tissue-Based Diagnostics was estimated to be worth US$ 5321 million in 2023 and is forecast to a readjusted size of US$ 8054.2 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030
Published: 2024-02-22
Pages: 110
USD 3950.00 (Single User License)
Global Tissue-Based Diagnostics Market Research Report 2024
The global Tissue-Based Diagnostics market was valued at US$ 5321 million in 2023 and is anticipated to reach US$ 8054.2 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Published: 2024-02-06
Pages: 81
USD 2900.00 (Single User License)